Clinical Trials Directory

Trials / Unknown

UnknownNCT05431829

Urdu Version of Fonseca Anamnestic Index: Reliability and Validity Study

Analysis of Psychometric Properties and Cultural Adaptation of Urdu Version of Fonseca Anamnestic Index in Pakistani Population

Status
Unknown
Phase
Study type
Observational
Enrollment
140 (estimated)
Sponsor
Riphah International University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The aim of study is to translate and culturally adapt Fonseca Anamnestic Index into Urdu language and to investigate the reliability and validity in Pakistani population over the age 18 years.

Detailed description

The English version of the Fonseca Anamnestic Index will be translated and culturally adapted as per previous recommendation. In Pakistani general population, Urdu Version of Fonseca Anamnestic Index will distributed among 140 participants choose by random sampling technique based on pre-defined inclusion and exclusion criteria. To test inter and intra-observer reliability of the final Urdu Version of Fonseca Anamnestic Index questionnaire will be filled on the same day, by two observers, and for the Inter-Observers assessment, with an interval of 30 minute between the first and the second application. Third assessment will carried out after 7 days by Observer-1, for intra-observer assessment. Data will be entered and analyzed using Statistical Package of Social Sciences Version 24. Internal consistency will be analyzed with Cronbach alpha value. Test- re-test reliability will be assessed using an intra-class correlation coefficient. The Urdu Version of Fonseca Anamnestic Index will be evaluated for content validity, construct validity, criterion validity and responsiveness.

Conditions

Timeline

Start date
2021-05-30
Primary completion
2022-07-10
Completion
2022-07-12
First posted
2022-06-24
Last updated
2022-06-24

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT05431829. Inclusion in this directory is not an endorsement.